Navigation Links
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
Date:3/8/2012

the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic indication, regulatory review and potential approval of Arena's most advanced drug candidate, lorcaserin; and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review is uncertain and Arena's applications for regulatory approval of lorcaserin may not be reviewed when anticipated; the EU application is subject to acceptance and confirmation by the EU regulatory agency that it is sufficiently complete to permit a substantive review; the FDA may not complete its review of the lorcaserin application by the PDUFA date; the occurrence, timing and results of FDA advisory committee meetings relating to lorcaserin and other drug candidates; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to lorcaserin and Arena's other research and development programs may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for regulatory review or approval; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the tim
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
2. Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
3. Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
4. Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Arena Submits Response to FDA Complete Response Letter for Lorcaserin
6. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
7. Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
8. Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
9. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
10. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
11. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Genuity 35th Annual Growth Conference at 8:30 a.m. EDT ... held August 12-13, 2015 at the InterContinental Boston. ...
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015 ... the world,s leading provider of diagnostic information services, ... announced acquisition of MemorialCare Health System,s laboratory outreach ... of the transaction, patients and physicians now have ... and network of nearly 200 patient service centers ...
(Date:8/4/2015)... SAN FRANCISCO , Aug. 4, 2015 /PRNewswire/ ... Nicki Vasquez , Ph.D., as vice president ... have a leadership role in the management of ... cancer therapeutics pipeline, including antibody-drug conjugates, bispecific antibodies ... Dr. Vasquez brings more than 22 years of ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2
... Mass., Jan. 17, 2012  CardioFocus, Inc., developer of ... treatment of atrial fibrillation (AF), announces that a ... Electrophysiology demonstrates the high acute and chronic ... procedure using HeartLight EAS. The study was conducted ...
... Inc. (NYSE Amex: PTN ) announced today ... of non-dilutive funding through the New Jersey Economic Development ... New Jersey net operating losses and research and development ... Palatin Technologies received approximately $637,000 under this program. ...
Cached Medicine Technology:Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 2Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 3Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 4
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... ... 2015 , ... Recent studies in the United ... binge drinking among certain populations and specific locations. Researchers, who have ... trends and evidence to help facilitate health care treatment to meet current needs. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Members receiving care ... care metrics – at a cost that is nine percent lower -- than those ... Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or ...
(Date:8/4/2015)... ... August 04, 2015 , ... Buckeye Health ... kindergarten. All required immunizations are covered for members under the Healthchek program . ... aren’t caught up with their immunizations may not be allowed to attend when ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... manufacturing, label design, product packaging, and fulfillment services, joined over 200 other Long ... event was held on Tuesday, July 28th at Jones Beach State Park in ...
Breaking Medicine News(10 mins):Health News:North Texas Acquisition Press Release 2Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2
... available in Spanish . , The ... Clinical Research of European Legislation ) a project with ... the European Directive on Clinical Trials (2001/20/EC) in all ... also has the active participation of the different stakeholders: ...
... public policy effort to boost safety , , MONDAY, July 28 ... in your town or your route to work through an ... of the need to drive safely. , Researchers at ... (CERS) developed www.saferoadmaps.org, so you can simply enter your address ...
... launches new website offering convenient http://www.terrimilen.com [Online Counseling via ... comfort of their own home or office. , ... ... provide clients with an alternative to traditional therapy which requires clients ...
... sample traced back to Mexican farm, FDA announces ... a week after uncovering the first big clue in ... that tainted jalapeno peppers had been definitively traced to ... Drug Administration gave the all-clear to jalapeno and serrano ...
... to discuss second quarter financial results -, LAVAL, ... DDSS) today announced that it will host a conference ... discuss its second quarter 2008,financial results. Labopharm will report ... approximately 7:00 a.m. the same day., To access ...
... function, increases asthma risk, studies find, , , FRIDAY, July ... actually be bad for your health, depending on what ... , Recent research suggests that exposure to cleaning products ... compound (VOC) called 1,4 dicholorobenzene (1,4 DCB), can reduce ...
Cached Medicine News:Health News:Researchers Map America's Deadliest Roads 2Health News:Online Counseling and Life Coaching Practice Launches New Website 2Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3
... Web-based and RFID-enabled location system that allows ... flow and utilization of resources throughout the ... collects patient information including location, and alerts ... experience. This information is directed to both ...
... Radianse indoor positioning solution ... of where and when ... flow through care processes. ... provides intelligence that hospitals ...
... enables healthcare facilities to provide a higher ... throughput utilizing one low cost infrastructure and ... Mobile Aspects active RFID tags, small enough ... and can house pertinent patient information such ...
VACUETTE PaediatricMulti-Sample Needle...
Medicine Products: